Microbial Cell-Free DNA Identifies the Causative Pathogen in Infective Endocarditis and Remains Detectable Longer Than Conventional Blood Culture in Patients with Prior Antibiotic Therapy

alexandrossfakianakis shared this article with you from Inoreader Microbial Cell-Free DNA Identifies the Causative Pathogen in Infective Endocarditis and Remains Detectable Longer Than Conventional Blood Culture in Patients with Prior Antibiotic Therapy via Clinical Infectious Diseases Advance Access Abstract Background The diagnosis of infective endocarditis (IE) can be difficult, particularly if blood cultures fail to yield a pathogen. This study evaluates the potential utility of microbial cell-free DNA (mcfDNA) as a tool to identify the microbial etiology of IE. Methods Blood samples from patients with suspected IE were serially collected. mcfDNA was extracted from plasma and underwent next-generation sequencing (NGS). Reads were aligned against a library containing DNA sequences belonging to >1400 different pathogens. mcfDNA from organisms present above a statistical threshold were reported and quantified in molecules/mL (MPM). Additional mcfDNA was collected on each subject every 2-3 days for a total of 7 collections or until discharge. Results Of 30 enrolled patients with suspected IE, 23 had Definite IE, 2 had Possible IE, and IE was Rejected in 5 patients by modified Duke Criteria. Only the 23 patients with Defi nite IE were included for analysis. Both mcfDNA and blood cultures achieved a sensitivity of 87%. The median duration of positivity from antibiotic treatment initiation was estimated to be approximately 38.1 days for mcfDNA vs 3.7 days for blood culture (proportional Odds 2.952, p= 0.02771), using a semi-parametric survival analysis. mcfDNA (log10) levels significantly declined (-0.3 MPM log10 units, 95% credible interval -0.45, -0.14) after surgical source control was performed (pre- vs post-procedure, posterior probability >0.99. Conclusion mcfDNA accurately identifies the microbial etiology of IE. Sequential mcfDNA levels may ultimately help to individualize therapy by estimating a patient's burden of infection and response to treatment. View on Web

Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.